• 2024-02-09
    IPO
    9375万美元
    未透露
  • 2023-01-05
    B轮
    1亿美元
    Symbiosis Group
    Catalio Capital Management
    Novo Holdings
  • 2022-01-25
    B轮
    1.75亿美元
    Bristol-Myers Squibb
    Farallon Capital Management
    Eventide Asset Management
    Marshall Wace
    Moderna Therapeutics
    Frazier Lifesciences Acquisition Corp
    Pura Vida
    Irving Investors
    Leaps by Bayer
    PFM Health Sciences
    Deep Track Capital
    RA Capital
    Surveyor Capital
    Millennium
    Novo Holdings
    Humboldt Fund
  • 加载更多